Development of 2A peptide-based strategies in the design of multicistronic vectors.
about
R26R-GR: a Cre-activable dual fluorescent protein reporter mouseThe herpes virus Fc receptor gE-gI mediates antibody bipolar bridging to clear viral antigens from the cell surfaceGeneration of healthy mice from gene-corrected disease-specific induced pluripotent stem cellsExpression of a humanized viral 2A-mediated lux operon efficiently generates autonomous bioluminescence in human cellsAn optimized triple modality reporter for quantitative in vivo tumor imaging and therapy evaluationHow (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferHigh cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and miceLentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.Dual fluorescent protein reporters for studying cell behaviors in vivo.A mouse reporter line to conditionally mark nuclei and cell membranes for in vivo live-imagingCoupling endonucleases with DNA end-processing enzymes to drive gene disruption.Human antigen-specific regulatory T cells generated by T cell receptor gene transfer.Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairsMembrane association of the CD3ε signaling domain is required for optimal T cell development and function.IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice.Expression characteristics of dual-promoter lentiviral vectors targeting retinal photoreceptors and Müller cells.Molecular imaging of transcriptional regulation during inflammationImmunologic applications of conditional gene modification technology in the mouseTransduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells.Specific increase in potency via structure-based design of a TCR.Use of mutated self-cleaving 2A peptides as a molecular rheostat to direct simultaneous formation of membrane and secreted anti-HIV immunoglobulinsc-Rel regulates Ezh2 expression in activated lymphocytes and malignant lymphoid cellsGenome editing in mouse spermatogonial stem/progenitor cells using engineered nucleases.Efficient generation of rat induced pluripotent stem cells using a non-viral inducible vector.Engineering improved T cell receptors using an alanine-scan guided T cell display selection systemInduction of pluripotent stem cells from a cynomolgus monkey using a polycistronic simian immunodeficiency virus-based vector, differentiation toward functional cardiomyocytes, and generation of stably expressing reporter lines.Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cells.Treating cancer with genetically engineered T cells.Viral bimolecular fluorescence complementation: a novel tool to study intracellular vesicular trafficking pathways.Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in miceA system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter.Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSVNCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maConstruction and applications of exon-trapping gene-targeting vectors with a novel strategy for negative selection.CRISPR/Cas9-mediated reporter knock-in in mouse haploid embryonic stem cells.Visualizing neuromodulation in vivo: TANGO-mapping of dopamine signaling reveals appetite control of sugar sensing.Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35.Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters
P2860
Q27316655-164592C8-D44E-43BB-A038-FEF0B7339A21Q27330259-521A23D9-EBB1-4D4C-9FCC-16A11CEEE413Q28478987-6D6792C2-468C-45AB-8635-0BAB8207C1AAQ28538398-D9C86C9C-EC42-481F-9369-C14F37C2D9D8Q28538698-D0C5BE32-19B8-4E7E-A9B7-6377AE99B921Q28727481-7AD627E1-A1EE-401C-A7C8-E47509972515Q28740624-9815753A-8693-4148-B2EC-E83321FAA4A1Q30499307-5A7FE4A3-850F-4EBE-AA89-D5714C908473Q30518785-C87F9DBC-20D2-48F6-8984-25A3EF9333F7Q30525543-210C7D00-787E-4D34-B37C-5F9F9B18F2AAQ30537830-F28130AC-94A6-49F8-A52A-4FC9FCAF9965Q33644234-257042F4-68C4-415B-B6E1-419ABAB1AF24Q33650603-280C0F3F-ACB4-4652-8070-18B64655FE80Q33698508-93B0D036-CAC5-47D9-BF3B-B6244A900670Q33787208-BA3A2343-BCB7-421D-91FC-DFA3E65FFAAAQ33839836-8443A9FB-0B4F-40B4-888F-551773C1220AQ33884609-4A8F40D8-3D90-45A6-A8A6-77C9CF057D8FQ33907256-076CC962-BE90-4A09-BA85-F7A513F4ABE4Q33908176-31CB5BA2-F111-4A02-8CB1-C1C49806FA4BQ34008900-E85110DB-03A0-4FD2-87A5-D7174E5CABB9Q34338895-F166EB95-62B6-4F55-A33A-39BB29F788FDQ34383054-570B578F-3563-4F62-A959-9977CB994CB2Q34500307-7E513771-E571-4F43-BD67-8388FC83F7D1Q34509582-8855912B-29C3-4991-A1CC-1E90185C5E3EQ34542214-D5FC342D-996C-4C34-8969-B799DBCC3988Q34576154-2C84632D-5272-4C25-921C-1F28B91BC7D4Q34624124-9347E3BA-77A0-41A8-8464-F031DD8C94A9Q34775239-54B61BA5-2D2E-49B3-96C8-1BBED41B36B5Q35161543-1441C68A-9874-48A3-B5C3-A414022E6D63Q35353365-97CF7EFB-7B38-4EDA-89F1-58FCC2FA6690Q35542711-7949F336-AE44-40D9-B153-71A9F4C47717Q35572462-F811FD6E-6C30-42CA-8EA3-6D88ABAB04A6Q35590371-DD171FED-8A92-41E0-8BCA-A1A7FC3867B7Q35591421-A863FF62-D56E-4E90-A8BD-7DEA0ABE880CQ35605318-F47ADEB3-F4E4-4E62-B93B-3F23CCC6304DQ35678076-0299E42E-48D9-46B9-8F97-6F7835628182Q35678972-92F88452-9D87-4722-B1EF-6B3D9A5EEFABQ35808759-0EE93DF8-A618-4FC4-A7C9-DC6BEAC04C6FQ35976659-1BABB128-42BF-425B-80E1-374F5987BDF2Q36053424-8FF6DBE6-E325-4319-84BF-DFAB7E4F6B82
P2860
Development of 2A peptide-based strategies in the design of multicistronic vectors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Development of 2A peptide-based strategies in the design of multicistronic vectors.
@ast
Development of 2A peptide-based strategies in the design of multicistronic vectors.
@en
type
label
Development of 2A peptide-based strategies in the design of multicistronic vectors.
@ast
Development of 2A peptide-based strategies in the design of multicistronic vectors.
@en
prefLabel
Development of 2A peptide-based strategies in the design of multicistronic vectors.
@ast
Development of 2A peptide-based strategies in the design of multicistronic vectors.
@en
P2860
P356
P1476
Development of 2A peptide-based strategies in the design of multicistronic vectors.
@en
P2093
Andrea L Szymczak
Dario A A Vignali
P2860
P304
P356
10.1517/14712598.5.5.627
P407
P577
2005-05-01T00:00:00Z